Clinical Trials Directory

Trials / Unknown

UnknownNCT06176742

Comparative Effects of ACBT and Bubble Positive Expiratory Pressure Device in Asthmatic Patients

Comparative Effects of Active Cycle Breathing Technique and Bubble Positive Expiratory Pressure Device in Asthmatic Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
42 (estimated)
Sponsor
Riphah International University · Academic / Other
Sex
All
Age
31 Years – 40 Years
Healthy volunteers
Accepted

Summary

The study gap is that in previous studies the effects of bubble-PEP in different diseases have been studied but it's never been studied in asthmatic patients, so the reason behind this study is to see effects of bubble-PEP in Asthmatic Patients.

Detailed description

The aim of this study was to determine the effect of Bubble-PEP device compared to ACBT in asthmatic patients. This study will be Randomized Clinical trial, Subject diagnosed with asthma meeting predetermined inclusion and exclusion criteria and will be divided into two groups. The baseline treatment for both groups would be diaphragmatic breathing exercises. While group A will be treated with ACBT and group B will be treated with bubble-PEP device. Each subject will receive 18 sessions with 3 treatments per week. Post treatment values will be recorded after the session and recorded values will be analyzed using SPSS 25

Conditions

Interventions

TypeNameDescription
OTHERActive Cycle Breathing TechniqueThis study will be Randomized Clinical trial, Subject diagnosed with asthma meeting predetermined inclusion and exclusion criteria and will be divided into two groups. The baseline treatment for both groups would be diaphragmatic breathing exercises. While group A will be treated with ACBT. Each subject will receive 18 sessions with 3 treatments per week. Post treatment values will be recorded after the session and recorded values will be analyzed using SPSS 25.
OTHERBubble Positive Expiratory Pressure DeviceThis study will be Randomized Clinical trial, Subject diagnosed with asthma meeting predetermined inclusion and exclusion criteria and will be divided into two groups. The baseline treatment for both groups would be diaphragmatic breathing exercises. While group B will be treated with bubble-PEP. Each subject will receive 18 sessions with 3 treatments per week. Post treatment values will be recorded after the session and recorded values will be analyzed using SPSS 25.

Timeline

Start date
2023-09-01
Primary completion
2024-01-01
Completion
2024-02-01
First posted
2023-12-20
Last updated
2023-12-20

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT06176742. Inclusion in this directory is not an endorsement.